Ascentage Pharma Group International (AAPG) stock
AAPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.01−0.13 (-0.97%)
Close on Nov 18, 2026Market cap $1.21BP/E –Yield –
Ascentage Pharma Group International revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was CN¥574.12M, down 41.5% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CN¥574.12M | -41.5% |
| FY2024 | Dec 31, 2024 | CN¥980.65M | +341.8% |
| FY2023 | Dec 31, 2023 | CN¥221.98M | +5.9% |
| FY2022 | Dec 31, 2022 | CN¥209.71M | – |
See a number that looks wrong?